Clincosm LogoSign in Get a demo

Timely Reperfusion in Acute ST-segment Myocardial Infarction

Sponsor
University Hospital of North Norway (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04614805
Collaborator
(none)
100
Enrollment
1
Location
26
Anticipated Duration (Months)
3.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of the study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mobilizing clinical leaders

Detailed Description

In the regional health trust of North Norway, time to reperfusion in acute ST-elevation myocardial infarction is below the national average and below recommendations. The aim of this study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients. The study period is supposedly lasting for approximately 4 months, the time estimated to observe the clinical course of 100 patients. Before and during the study period, clinical leaders are encouraged to improve guideline adherence and to closely monitor the results of their own and collaborating institutions.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Mobilizing Clinical Leadership to Achieve Timely Reperfusion in Acute ST-segment Elevation Myocardial Infarction
Actual Study Start Date :
Nov 1, 2020
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Outcome Measures

Primary Outcome Measures

  1. Time to reperfusion [This parameter will be recorded within 1 week after patient inclusion]

    Interval between 1st medical contact and opening of the infarction-related coronary artery.

Secondary Outcome Measures

  1. Ejection fraction at discharge [This parameter will be recorded up to 6 months after patient inclusion]

    Systolic function of the left ventricle

  2. Survival [This parameter will be collected from patient's records during Nov -20 till Aug -21.]

    Survival after 30 days from incident

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient diagnosed with acute myocardial infarction with ST-elevations within our regional health trust during Nov 1st and for approx 4 months, and with an indication for reperfusion therapy (thrombolysis and/pr PCI)
Exclusion Criteria:
  • Reperfusion therapy not indicated or contraindicated

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital North Norway Tromsø Troms Og Finnmark Norway 9038

Sponsors and Collaborators

  • University Hospital of North Norway

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kristian Bartnes, Director of Division of Cardiothoracic and Respiratory Medicine, University Hospital of North Norway
ClinicalTrials.gov Identifier:
NCT04614805
Other Study ID Numbers:
  • iTide
First Posted:
Nov 4, 2020
Last Update Posted:
May 19, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Myocardial Infarction
Infarction

Study Results

No Results Posted as of May 19, 2022